ArticleHealthcare (Basel, Switzerland)2024
Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus.
Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- The cost of cancer care: how much would you pay for your drugs? Patient and oncology professional stakeholder opinions in Ireland.Irish journal of medical science · 2026Article
- Ethical Considerations in Health Technology Assessment for Precision Medicine: A Delphi Study in a Greek Setting.Journal of personalized medicine · 2026Article
- Practice and challenges of HB-HTA in China: insights from hospital management and clinical perspectives.International journal of technology assessment in health care · 2026Article
- Exploring the challenges of developing hospital-based health technology assessment in Iran: a qualitative study.Health research policy and systems · 2026Article
- The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease in Slovenia: An Umbrella Review and Economic Evaluation.Healthcare (Basel, Switzerland) · 2026Article
- Advancing hospital-based health technology and impact assessments: institutionalizing strategic decision-making in innovation adoption.International journal of technology assessment in health care · 2026Article
- Bridging the gap between evidence and practice: introducing hospital-based health technology assessment in Ukraine.International journal of technology assessment in health care · 2025Article
- Hospital-based health technology assessment of central dialysis fluid delivery system for hemodialysis patients.BMC nephrology · 2025Article
- Political analysis of health technology assessment implementation in Iran.Health research policy and systems · 2025Article
- Connecting minds and catalyzing collaboration: the interest groups of health technology assessment international.International journal of technology assessment in health care · 2025Review
- Optimizing Patient Access to Orphan Medicinal Products: Lessons from Central and Eastern Europe.Journal of market access & health policy · 2025Article
- The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey.International journal of technology assessment in health care · 2025Article
- Driving policy dialogue on health technology assessment in Eastern Europe and Central Asia: reporting from an initiative of Health Technology Assessment International.International journal of technology assessment in health care · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries. Through a two-round Delphi study, insights were gathered from a panel of 15 HTA specialists from France, Hungary, Italy, Kazakhstan, Poland, Switzerland, and Ukraine. Experts initially conducted a comprehensive review of the HB-HTA implementation in their respective countries, identifying the barriers and facilitators through descriptive analysis. Subsequently, panel experts ranked these identified barriers and facilitators on a seven-point Likert scale. A median agreement score ≥ 6 and interquartile range (IQR) ≤ 1 was accepted as reaching a consensus. Out of the 12 statements categorized as external and internal barriers and facilitators, the expert panel reached consensus on six statements (two barriers and four facilitators). The external barrier, which achieved consensus, was the lack of the formal recognition of the role of HB-HTA in national or regional legislations. The internal barrier reaching consensus was the limited availability of human resources dedicated to HB-HTA. This qualitative study indicates that HB-HTA still has progress to make before being formally accepted and integrated across most countries, although by building on the facilitating factors we identified there may be an opportunity for the implementation of internationally developed strategies to strengthen HB-HTA practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.